H-CORT OINTMENT 1% WW

国: マレーシア

言語: 英語

ソース: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

有効成分:

HYDROCORTISONE BASE

から入手可能:

HOE PHARMACEUTICALS SDN. BHD.

INN（国際名）:

HYDROCORTISONE BASE

パッケージ内のユニット:

15 gm mcg/mL; 450 gm mcg/mL

製:

HOE PHARMACEUTICALS SDN. BHD.

情報リーフレット

_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
H-CORT OINTMENT
Hydrocortisone (1% w/w)
1
WHAT IS IN THIS LEAFLET
1.
What
H-Cort
Ointment
is
used for
2.
How H-Cort Ointment works
3.
Before
you
use
H-Cort
Ointment
4.
How to use H-Cort Ointment
5.
While you are using H-Cort
Ointment
6.
Side effects
7.
Storage and Disposal of H-
Cort Ointment
8.
Product description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of Revision
This leaflet answers some common
questions about
_ _
H-Cort Ointment.
It does not contain all the available
information. It does not take the
place of talking to your pharmacist
or doctor.
All
medicines
have
risks
and
benefits. Your pharmacist or doctor
has weighed the risks of you taking
H-Cort
Ointment
against
the
benefits they expect it will have for
you.
Keep this leaflet with the medicine.
You may need to read it again.
WHAT H-CORT OINTMENT IS USED
FOR
H-Cort
Ointment
is
used
to
suppress
skin
disease
in
which
inflammation
is
the
prominent
feature.
These
skin
problems
include eczema, infantile eczema,
atopic
dermatitis,
dermatitis
herpetiformis,
contact
dermatitis,
neurodermatitis,
psoriasis
and
intertrigo.
HOW H-CORT OINTMENT WORKS
H-Cort
Ointment
contains
a
medicine called hydrocortisone. It
belongs to a group of medicines
called
steroids.
It
has
anti-
inflammatory,
anti-itching
and
blood vessel narrowing actions.
Ask your pharmacist or doctor if
you have any questions about this
medicine.
BEFORE YOU USE H-CORT OINTMENT
_ _
-
_When you must not use it _
Do not use H-Cort Ointment if you
are
allergic
(hypersensitive)
to
hydrocortisone,
other
corticosteroids, or any of the other
ingredients in this medicine.
-
_Before you start to use it _
Tell your pharmacist or doctor if
you
are
applying
the
ointment
under
an
airtight
dressing,
including a child’s nappy. These
dressings
make
it
easier
for
the
active ingredient to pass through
the
skin.
It
is
possible
to
accidentally end up using too much
ointment.
Pregnancy and breast feeding:
•
Ask your doctor or pharmacist
for
advice
befo

製品の特徴

Est. 1979
H-CORT CREAM & OINTMENT 1% W/W
NAME AND STRENGTH OF ACTIVE SUBSTANCE: Hydrocortisone 1% w/w.
PRODUCT DESCRIPTION:
CREAM: A white cream.
Other
ingredients: White
soft
paraffin,
Liquid
paraffin,
Chlorocresol,
Cetostearyl
alcohol,
Propylene glycol, Macrogol cetostearyl ether (Cetomacrogol 1000) and
Purified water.
OINTMENT: A white ointment.
Other ingredients. White soft paraffin and Liquid paraffin.
PHARMACODYNAMICS
:
Hydrocortisone
is
a
topically
active
corticosteroid
which
has
anti-inflammatory, antipruritic and vasoconstrictive actions.
PHARMACOKINETICS : Corticosteroids are extensively bound to plasma
protein.
Only
unbound
corticosteroids
has
pharmacological
effects
or
is
metabolised. They
are
metabolised mainly in the liver and also in the kidney, and are
excreted in the urine.
INDICATIONS : Suppression of skin diseases in which inflammation is a
prominent feature, e.g.
eczema,
infantile
eczema,
atopic
dermatitis,
dermatitis
herpetiformis,
contact
dermatitis,
neurodermatitis, psoriasis and intertrigo.
CONTRAINDICATION
:
Hypersensitivity
to
hydrocortisone,
other
corticosteroids,
or
any
component in the base.
DRUG INTERACTION : Not known.
ADVERSE EFFECT : Reported local adverse reactions are burning
sensation, itching, irritation,
dryness, folliculitis, hypertrichosis, acneiform eruptions,
hypopigmentation, maceration of the
skin, secondary infection, skin atrophy, striae and miliaria. Systemic
adverse reactions, such as
vision blurred, have also been reported with the use of topical
corticosteroids.
PRECAUTIONS/WARNINGS: Discontinue use if irritation, sensitivity or
other reaction develop
and institute appropriate treatment. Corticosteroid applied to the
skin can be absorbed in
sufficient amount to produce systemic effects such as
hypothalamic-pituitary-adrenal axis
suppression, manifestation of Cushing's syndrome, hyperglycaemia and
glucosuria. Thus
suitable precautions should be taken during prolonged treatment, when
treating extensive body
surface areas, when using the occlusive technique and when